The global epilepsy drugs market was valued at USD 10 billion in 2022 and grew at a CAGR of 4% from 2023 to 2032. The market is expected to reach USD 14.80 billion by 2032. The increasing prevalence of epilepsy will drive the growth of the global epilepsy drugs market.
Det opplastede innholdet vil bli flyttet til det nylig opprettede albumet. Du må opprett konto eller logg inn hvis du ønsker å endre dette albumet senere.